Position Statements, Practice Statements, and Practice Guidelines

The need for authoritative guidance in pediatric pharmacy practice has grown with changes in health care and with shifting influences from regulatory, accrediting, risk-management, financing, and other bodies. The PPA Advocacy Committee develops official professional position statements for this purpose.

PPA offers therapeutic position statements that respond to specific therapeutic issues. These statements are thorough, evidence-based recommendations of drug use. PPA also offers position statements on public policy issues that are directed to health care professionals, public officials, and the general public.

PPA position statements provide guidance and direction to PPA members, pharmacy practitioners, and other audiences who affect pharmacy practice. Their use by members and other practitioners is strictly voluntary, and their content should be assessed and adapted to meet the needs of specific practice settings.

Below is a list of our guidelines and position statements: 

Endorsing Statement Following CDC ACIP Meeting from Nation’s Leading Doctors, Nurses, Pharmacists and Public Health Leaders on Benefits of Vaccination (2021)

Importance of Pediatric Studies in SARS-CoV-2 Vaccine Development (2021)

PPA Endorses HHS action allowing for the provision of childhood vaccines by pharmacists (2020)

Endorsement of the Statement "National Pharmacy Organizations Unite to Take a Stand Against Racial Injustice" (2020)

Joint Statement: Response to HHS Statements on Authorizing Licensed Pharmacists to Order and Administer COVID-19 Tests (2020)

Endorsement of the Joint Statement of America's Frontline Physicians Opposing Public Charge Final Rule (2019)

Standardization of Concentrations for Extemporaneously Compounded Oral Liquid Medications (2019)

Endorsement of the Joint Statement Supporting the VACCINES Act (2019)

Credentialing pharmacists and Collaborative Practice (2019)

Opioid Use in Children (2019)

Pediatric Pharmacists' Participation Cardiopulmonary Resuscitation Events (2018)

The Role of the Pediatric Pharmacist in Precision Medicine and Clinical Pharmacogenomics for Children ​(2018)

Pharmacists and Childhood Vaccines (2018)

ASHP-PPAG Guidelines for Providing Pediatric Pharmacy Services in Hospitals and Health Systems (2018)

Endorsing the American Academy of Pediatrics (AAP) Statement on Gun Violence: A Letter to Our Members (2018)

Endorsed the Institute of Safe Medication Practices (ISMP) Medication Safety Self Assessment for High-Alert Medications (2017)

Medication dosing in overweight and obese children (2017 update)

Duty to Advocate: Human Papillomavirus Vaccination (2017 update)
[[In the Press: Pharmacy Times]]

Pediatric Antimicrobial Stewardship Programs (2017 updated)

Heparin Safety Concerns (2016)

Minimum requirements for core competency in pediatric pharmacy practice (2015)

Drug Shortages and the Implications for Pediatric Patients (2015)

Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: Time for Permanent Status​ (2012)

Pediatric pharmacist’s participation in cardiopulmonary resuscitation events (2012)

Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group (2012)

The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics in children (2011)

Statement on antidepressant use in children (2009)

Statement on self-administration of asthma medication for school-aged children (2003, legacy paper)

Guidelines for preventing medication errors in pediatric patients (2001, legacy paper)